Vigilant Capital Management, LLC 10x Genomics, Inc. Transaction History

Vigilant Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 06, 2022	BUY	$36.95 - $82.41 $4.44 Million - $9.91 Million	120,257 Added 155.81%	197,440 $8.93 Million
Q1 2022 Apr 07, 2022	BUY	$55.7 - $145.79 $331,192 - $866,867	5,946 Added 8.35%	77,183 $5.87 Million
Q4 2021 Jan 06, 2022	BUY	$135.05 - $182.59 $1.05 Million - $1.41 Million	7,749 Added 12.21%	71,237 $10.6 Million
Q3 2021 Oct 08, 2021	BUY	$145.58 - $192.14 $212,692 - $280,716	1,461 Added 2.36%	63,488 $9.24 Million
Q2 2021 Jul 09, 2021	BUY	$134.22 - $202.37 $595,534 - $897,915	4,437 Added 7.7%	62,027 $12.1 Million
Q1 2021 Apr 16, 2021	BUY	$140.25 - $196.86 $8.08 Million - $11.3 Million	57,590 New	57,590 $10.4 Million

292

94.7M

263K

85.1K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.48B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Vigilant Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Vigilant Capital Management, LLC with notifications on news.